My Medication Side Effects Are Too Popular

In the afternoon, Fu Xinming went to Bingcheng Pharmaceutical Group,

Zheng Xianmin poured Fu Xinming a cup of tea himself: "Old classmate

You are very busy now, why do you still have time to come to me for tea?

Zheng Xianmin is also very proud of the spring breeze recently, especially since his career is booming, taking over the chairmanship of Bingcheng Pharmaceutical Group is a certainty.

Have to wait half a year.

With the help of Xinming Pharmaceutical, he has obtained more than a dozen new drug patents from so many top foreign pharmaceutical companies

Although many conditions are relatively harsh, it is finally possible to get these drug patents, whether it is for Bingcheng Pharmaceutical Group or domestic patients.

have big benefits

In the next five years, Bingcheng Pharmaceutical Group will not dare to say that it will have outstanding performance in the international market, but in the domestic market, it will definitely take a big step forward again and become one of the third

So he was very happy to see Fu Xinming. Thanks to the help of his old classmates, he was able to have such a good opportunity.

Fu Xinming took a sip of tea and put down the teacup: "I came to you for help.

Zheng Xianmin was a little surprised: "Your company is not short of money and technology now, and Johnson & Johnson is also helping you in sales. Do you still need me? Tell me, what's the matter?

I will never refuse if I can.

"I hope that as long as the Bingcheng Group announces to the public, in the next two years, it will increase the production and sales of broad-spectrum drugs, and use new processes to increase production capacity and reduce

Low prices, especially in the seven northern provinces and cities.

Du Xianmin was stunned for a moment: "Old classmate, you are embarrassing me.

"With your help, we have just obtained so many patents for analgesics, and we are about to develop this business in a big way. Broad-spectrum drugs are originally

The profit is low, and the price has to be reduced. The board of directors may not be able to pass it.

"And why did you let me do this?

Fu Xinming smiled: "I want to buy Tianlong Pharmaceutical Group!

Zheng Xianmin realized after thinking about it. Whether it is from the perspective of emotion or company interests, Xinming Pharmaceutical's acquisition of Tianlong Pharmaceutical Group is a good step.

But the other party is definitely not willing, so let Bingcheng Pharmaceutical Group take away the market of Tianlong Pharmaceutical Group and force the other party's shareholders to agree.

It's just that this doesn't do any good to Bingcheng Pharmaceutical Group. He is willing to help, but the directors will not agree.

.This is a state-owned enterprise, not him.

Fu Xinming saw Zheng Xianmin's hesitation and continued: "Old classmate, how can I make you embarrassed?

'After we acquired Tianlong Pharmaceutical Group, we will also give up the production and sales of broad-spectrum drugs,

, in the future only new special medicines will be produced, and this market will be exhausted.

All to you Bingcheng Pharmaceutical Group.

"Although it's not too much, it's still possible to increase the profit of Bingcheng Pharmaceutical Group by [-] million a year, right? Can you help now?

The expression on Zheng Xianmin's face loosened: "Okay, then I can be sure to persuade the board of directors to agree. Don't worry, two days at the latest,

Must give you a satisfaction

reply!

Three days later, Bingcheng Pharmaceutical Group announced that it would increase the production and sales of broad-spectrum drugs, especially in the seven northern provinces and cities.

After this news was announced, the share price of Tianlong Pharmaceutical Group immediately fell rapidly.

The meeting room of Tianlong Pharmaceutical is holding the shareholders' meeting

A few times a year is enough, most of the time it is enough to hold a board meeting.

- Under normal circumstances, the company's general meeting of shareholders is not often held,

But this year, Tianlong Pharmaceutical has held more than a dozen shareholder meetings.

From the initial negotiation to launch the chemical and pharmaceutical research and development laboratory, to the negotiation of the acquisition of the laboratory of Xinming Pharmaceutical, and then to the launch of the new drug of Tianlong Pharmaceutical, the new drug was acquired.

There are too many things that affect the interests of the company's shareholders, such as eliminating approval documents, changing board members, and introducing new shareholders.

This time, Tianlong Pharmaceutical has encountered a dilemma again

"Dear shareholders, we spent [-] million in cash to buy the painkiller formula in Mike Joe's hand, but that painkiller formula has been scouted by the market.

"Although we have not paid the subsequent balance, the [-] million deposit cannot be recovered.

"Originally, we rely on the production and sales of broad-spectrum drugs to maintain the normal operation of the company. When our antihypertensive drugs are launched, we will be able to obtain asthma

"But the existing Bingcheng Pharmaceutical Group does not know why it announced that it will expand the Guangnuo drug market in the seven northern provinces and cities, and will rely on new production

Technologically, the price of medicines has dropped, so what is it to make people able to afford reassuring medicines?

"They have a lot of patents on anti-cancer drugs, and they can make more money with this, and they can use broad-spectrum drugs to make a name for themselves. We are almost done.

"The news spread, our stock started to fall again, and now a solution has to come.

Liu Chen sat on the throne. When Sun Zhiwei sat here, he was very envious and even jealous.

But when he was sitting here, he was on pins and needles!

He was afraid that, like Sun Zhiwei, he would be ousted by other shareholders, or even become a scapegoat for the company's losses, and he wanted to compensate other shareholders for their losses.

What made him even more uncomfortable was that Xinming Pharmaceutical sent a takeover offer to them, saying that it was to meet the rapidly growing drug orders in the future.

Production capacity, I think Tianlong Pharmaceutical is not bad.

A few months ago, it was Tianlong Pharmaceutical who wanted to acquire Xinming Pharmaceutical, but now the situation has turned around so quickly!

The faces of the shareholders are ugly. The share price of Tianlong Pharmaceutical Group continues to fall, which is not a good thing, and it means that their net worth has shrunk.

The acquisition of Xinming Pharmaceutical is more like a slap in the face of all their shareholders.

With head-to-head competition, how could they be the opponents of Xinming Pharmaceutical now?

The cash flow that Xinming Pharmaceutical can use now is higher than their market value!

But even if Tianlong Pharmaceutical Group wants to sell its shares, it cannot sell it to Xinming Pharmaceutical, otherwise they will become a joke in the industry!

Gu Yinqi frowned: "There are so many good drugs on the market now, can't Tianlong Pharmaceutical make generic drugs? For example, sildenafil

He doesn't usually buy medicine himself, but he buys sildenafil a lot. The young man does not know how precious X is.

, now can only rely on medicine to feed!

He didn't mind selling the shares of Tianlong Pharmaceutical, it was just an investment anyway.

But he did not intend to sell to Xinming Pharmaceutical

If it weren't for Xinming Pharmaceutical, Li Xinchuan and Xinmei Cosmetics Co., Ltd. would already belong to him. In the future, there is a great chance to share the shares of Li's Group.

Now, it's all gone!

Xinming Pharmaceutical made him unhappy, and he would not make Xinming Pharmaceutical happy.

You want to expand capacity,

, I won't let you buy it!

Liu Chen's eyes lit up:

"Gu Shao's words reminded me that we can continue the generic drugs that we are good at.

"Sildenafil is really good. The sales of this drug in China have continued to rise. Ziyunshan's stock price has risen a lot with this, and it sells better than Pfizer's.

"We can copy this drug,

It can sell at least several hundred million a year, and it can drive the stock price to rise.Even we can go directly to buy the pharmaceutical process

This makes production faster.

"After the stock price rises, we can apply for a loan from the bank again, and the company's crisis can be smoothly overcome.

The other shareholders also nodded their heads. They, Tianlong Pharmaceuticals, are the best at generic drugs. They also started with generic drugs before.

Anyway, Pfizer's sildenafil patent protection period has expired, and they can get this cup!

Everyone figured it out. The company still has [-] million working capital. If you are willing to spend money, you can complete the process research and development of generic drugs in a very short time.

Even spend a sum of money directly to purchase the production process, and the rest is used to compete with the Bingcheng Pharmaceutical Group for the market of broad-spectrum drugs. At this time, it must not collapse!

They don't need to wait for their sildenafil to go public. As long as they announce the success of research and development, the stock price will rise!

And after the stock price rises, the company's market value will also become higher, and you can borrow money from the bank again, so as to survive the crisis of insufficient funds!

, must be able to fight a beautiful turnaround!

"Don't worry, shareholders, we Tianlong Pharmaceutical will not fail, this time relying on sildenafil,

PS: The flowers that are full of nine stems will be delivered.Ask for flowers, ask for evaluation, ask for collection!!!

Of

Chapter [-]: To force Xinming Pharmaceutical to cooperate with us Pfizer

The board of directors of Rui company, the directors of the company are sitting together, their faces are not very good-looking

Their reports will still look good this year, but not next year.

Johnson & Johnson has cooperated with the Minsheng Pharmaceutical in the East, and a number of new drugs have begun clinical testing around the world

There is no need for them to inquire at all, and Johnson & Johnson itself constantly publishes the data of clinical tests.

Let’s not talk about Supain, it is destined to become the most popular painkiller in the market in the next few years, and even after the patent protection expires, I am afraid there will be no enterprises.

able to compete.

I only hope that after taking this drug for a long time, there will be some harmful side effects to the human body, so as to slow down the development of Johnson & Johnson and Xinming Pharmaceuticals

With bovine hair medicine, hair removal cream, etc., the effects are all very magical.

Even some big Hollywood stars are trying to find a way to become one of the clinical trial people